title: DxS Ltd.
abstract: DxS is a pharmacogenomics business operating at the interface between genetic diagnostics and the pharmaceutical industry. The company strategy is to enable pharmacogenomics by the provision of genetic analysis services to the healthcare sector. The services provide support for drug discovery, drug development and also drug marketing via the introduction of "personalized medicines". Rather than specialize in a particular field of medicine, DxS has chosen to operate on a fee for service basis and concentrate on the provision of exceptional levels of customer, technical and logistical support to facilitate the development and introduction of pharmacogenomics. A major focus is the provision of genetic analysis services to support clinical trials and consequently the service operation is carried out under stringent quality systems. The business is also developing the Genetwork--a global alliance of diagnostic service laboratories to provide the diagnostic genotyping needed to implement personalized medicine.
authors.affiliation: DxS Ltd, 48 Grafton St., Manchester, M13 9XX, UK. stephen.little@dxsgenotyping.com
authors.forename: Stephen
authors.initials: S
authors.lastname: Little
mesh_terms: D004345:Drug Industry / Q000639:trends*; D004739:England; D010597:Pharmacogenetics / Q000639:trends*; D012106:Research / Q000639:trends